Owner and operator
glp1telehealthreviews.com is owned and operated by Sam LLC. Sam LLC provides educational information only. Always consult a qualified healthcare provider before starting any medication.
Financial relationships with providers
We may earn a commission when a reader clicks a link to a GLP-1 provider on this site and subsequently makes a purchase or signs up for a service. These affiliate relationships are described in full on the affiliate disclosure page. Affiliate commissions do not change the price a reader pays and do not enter the pricing database, the value score, category results or rankings, all of which are computed by published code from verified prices and terms.
Partners, sponsored placements and commercial relationships
This site is operated in partnership with NexLife (nexlife.us), a compounded-GLP-1 telehealth provider listed and ranked on this site. The partnership is commercial: NexLife's plan pages are linked from the site-wide Editor's pick module and from its review with rel="sponsored" links, the module carries the partnership label, and we may earn commissions on sign-ups through those links. What the partnership does not do is stated in the next paragraph and enforced by the build: NexLife's prices are recorded from its own pages by the same process as every other provider's, its value score is computed by the same published formula, and its rank on every price page is whatever the formula produces — as of September 12, 2026 that is fifth of thirty-four on tirzepatide 12-month cost and fifth of sixteen on semaglutide, behind SnagRx, Embody and Trimi. The Editor's pick module features the provider with the highest value score in the database at build time and changes automatically when the data changes; NexLife currently holds it by one point over SnagRx. Facts a provider supplies for its own module (plan pages, included services, stated values) are labeled as the provider's statements where we have not verified them independently. Any further partner or sponsor will be named here and on the advertising disclosure page, which is regenerated on every build so it cannot fall out of date, and labeled wherever it appears.
What no commercial relationship can do: change a price in the database, a verification status, a value score, a category result or a rank. Those are computed by published code from prices recorded on every provider's own pages, and the code and the data are downloadable so the arithmetic can be checked. Where the Editor's pick is not the best choice for a reader, the relevant pages say so and link to the provider that is.
The NexLife partnership is the only commercial relationship with a listed provider beyond ordinary affiliate commissions. Any ownership interest, investment, employment, licensing or other arrangement between Sam LLC, its principals or staff and any listed provider, if one exists or comes to exist, will be stated in this section by name and nature. Information supplied by providers (pricing, service descriptions, anonymized patient questions) is treated as provider-stated until verified against public pages.
Why this matters for you
A review site that recommends a provider it owns, without saying so, is deceptive under the Federal Trade Commission's endorsement guides (16 CFR Part 255) and would be discounted by readers and by the search and answer engines that cite comparison content. Our protection against that outcome is structural: rankings come from data, the data is public, the calculation is published, and every relationship is disclosed here. If our interests and yours ever diverge, the data lets you check.
Contact
Questions about ownership or relationships: contact page or editor@glp1telehealthreviews.com.